Condition
Stem Cell Leukemia
Total Trials
3
Recruiting
0
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (1)
P 3 (1)
Trial Status
Completed1
Active Not Recruiting1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04980404Phase 1Active Not Recruiting
Inqovi Maintenance Therapy in Myeloid Neoplasms
NCT04044560Phase 2Terminated
Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant
NCT03825887Phase 3Completed
Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients
Showing all 3 trials